Ganglioneuroblastoma — Trials

Ganglioneuroblastoma — Trials · CancerIndex

Clinical trials

Registered studies

20 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 6
Ph III recruiting: 4
Growth YoY: —
Industry share: 8%
Top sponsor: Children's Oncology Group
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07437963	Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse	not yet recruiting	Phase 1 / Phase 2	76	National Cancer Institute (NCI)NIH	0	Sep 9, 2026	clinicaltrials
NCT02311621	Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01	active not recruiting	Phase 1	65	Seattle Children's HospitalOTHER	1	May 19, 2026	clinicaltrials